Speech-Language Pathologists in Cleveland, TN Accepting Medicare

23 Speech-Language Pathologists found. Showing 21 - 23

Amanda Gayle Scott, SLP/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 S Lee Hwy, Cleveland, TN 37311 Phone: 423-622-1551

Nathanael Webb Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2735 Patterson Rd Se, Cleveland, TN 37323 Phone: 423-943-9211

Leigh Michaels, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 S Lee Hwy, Cleveland, TN 37311 Phone: 423-476-0620    Fax: 423-476-0485

News Archive

Patients with RA today have easier time with daily living than patients diagnosed two decades ago

New research reveals that patients with rheumatoid arthritis today have an easier time with daily living than patients diagnosed two decades ago. According to results of the study published in Arthritis Care & Research, a journal of the American College of Rheumatology, anxiety, depressed mood and physical disability have been cut in half over the last 20 years. Researchers believe a reduction in disease activity is partly responsible for this positive change.

750,000 Americans will have a stroke or brain attack this year

Today researchers from the University of Washington School of Medicine reported findings that suggest that not all stroke patients have equal access to the only Federal Food and Drug Administration (FDA) approved acute ischemic stroke treatment.

Sexual activity appears to be on the decline among Americans

Americans are having less sex than they did 25 years ago, with the sharpest decline being seen among married people, according to research published in Archives of Sexual Behavior.

Is it preferable for patients' families or doctors to make tragic choices?

In the medical realm, people sometimes need to make very difficult choices, such as deciding to end life-support for a terminally ill patient.

FDA Advisory Committee votes in favor of Actavis' ceftazidime-avibactam

Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)